請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37920
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 江俊斌 | |
dc.contributor.author | Hsien-Yen Hung | en |
dc.contributor.author | 洪千雁 | zh_TW |
dc.date.accessioned | 2021-06-13T15:51:12Z | - |
dc.date.available | 2008-08-13 | |
dc.date.copyright | 2008-08-13 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-06-25 | |
dc.identifier.citation | Ambrosch P, Kron M, Fischer G, et al. Micrometastases in carcinoma of the upper aerodigestive tract: detection, risk of metastasizing, and prognostic value of depth of invasion. Head Neck 1995;17:473-9.
Alvi A, Johnson JT. Extracapsular spread in the clinically negative neck (N0): implications and outcome. Otolaryngol Head Neck Surg 1996;114:65–70. Barrera J, Miller M, Said S, Jafek BW, Campana JP, Shroyer KR. Detection of occult cervical micrometastases in patients with head and neck squamous cell cancer. Laryngoscope. 2003;113:892-6. Carter RL, Bliss JM, Soo KC, O’Brien CJ. Radical neck dissections for squamous carcinomas: pathological findings and their clinical implications with particular reference to transcapsular spread. Int J Radiat Oncol Biol Phys 1987;13:823–32. Cote RJ, Peterson HF, Chalwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management breast cancer. Lancet 1999;354:896-900. Cortesino G, Sacchi M, Galeazzi E, De Stefani A. Immunology of head and neck cancer: perspectives. Head Neck 1993; 15: 74-7. Domagala W, Bedner E, Chosia M, et al. Keratin-positivereticulum cells in fine needle aspirates and touch imprints of hyperplastic lymph nodes. Acta Cytol 1992;36:241-5. Devaney SL, Ferlito A, Rinaldo A, et al. The pathology of neck dissection in cancer of the larynx. ORL J Otorhinolaryngol Relat Spec 2000;62:204-11. Dowlatshahi K, Fan M, Bloom KJ, et al. Occult metastases inthe sentinel lymph nodes of patients with early stage breast carcinoma. Cancer 1999;86:990-6. Don D, Anzai Y, Lufkin RB, et al. Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Laryngoscope 1995;105:669-74. Enepekides D, Sultanem K, Nguyen C, et al. Occult cervical metastases: Immunoperoxidase analysis of the pathologically negative neck. Otolaryngol Head Neck Surg 1999;120:713-7. Elias JM. Immunohistochemical approach to the diagnosis of malignant disease. In: Elias JM, ed. Immunohistopathology: A Practical Approach to Diagnosis. Chicago: ASCP Press, 1990:91–147. Friedman M, Mafee MF, Pacella BL, Strorigl TL, Dew LL, Torumi DM. Rationale for elective neck dissection in 1990. Laryngoscope 1990;100: 54-9. Ferlito A, Rinaldo A. False negative conventional histology of lymph nodes in patients with head and neck cancer. ORL 1000;62:112-4. Feinmesser R, Freeman JL, Feinmesser M, Noyek A, Mullen JBM. Role of modern imaging in decision-making for elective neck dissection. Head Neck 1992;14: 173-6. Grandi C, Malloisio E, Moglia D, et al. Prognostic significanceof lymphatic spread in head and neck carcinoma: therapeuticimplications. Head Neck Surg 1985;8:67-73. Glickman JN, Torres C, Wang HH, et al. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer 1999;85:769-78. Greenson JK, Isenhart CE, Rice E, et al. Identification of occult micrometastases in pericolic lymph nodes of Duke’s B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 1994;74:563-9. Gould VE, Bloom KJ, Franke WW, et al. Increased number of cytokeratin-positive interstitial reticulum cells (CIRC) in reactive, inflammatory and neoplastic lymphadenopathies: hyperplastic or induced expression? Virchows Arch 1995;425:617-29. Hamakawa H, Takemura K, Sumida T, Kayahara H, Tanioka H, Sogawa K. Histological study on pN upgrading of oral cancer. Virchows Arch. 2000;437:116-21. Ho CM, Lam KH,WeiWI, Lau SK, Lam LK. Occult lymph node metastasis in small oral tongue cancers. Head Neck 1992;14:359-63. Ishigami S, Natsugoe S, Tokuda K, et al. Clinical impact of micrometastasis of the lymph node in gastric cancer. Am Surg 2003;69:573-7 Jensen J, Andersen J. Lymph node identification in carcinoma of the colon and rectum. Acta Pathol Microbiol Scand. 1978;86:205-9. Johnson JT, Barnes EL, Myers EN, et al. The extracapsular spread of tumors in cervical node metastases. Arch Otolaryngol 1981;107:725-9. Komukai S, Nishimaki T, Watanabe H, et al. Significance of immunohistochemically demonstrated micrometastases to lymph nodes in esophageal cancer with histologically negative nodes. Surgery 2000;127:40-6. Kligerman J, Lima RA, Soares JR, Prado L, Dias FL, FreitasEQ, et al . Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg 1994;168:391-4. Kruyt RH, Van Putten WL, Levendag PC, et al. Biopsy of nonpalpable cervical lymph nodes: selection criteria for ultrasound- guided biopsy in patterns with head and neck squamous cell carcinoma. Ultrasound Med BioI 1996;22:413-9. Kenneth O. Devaney, MD, JD, FCAPa, et al. Micrometastases in cervical lymph nodes from patients with squamouscarcinoma of the head and neck: should they be actively sought? Maybe. Am J Otolaryngol 2007;28:271-4. Lindemann F, Schlimok G, Dirschedl P, et al. Prognostic significanceof micrometastatic tumor cells in bone marrow of colorectal cancer patients. Lancet 1992;340:685-9. Leemans CR, Tiwari R, Nanta JJP, et al. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993;71:452-6. Melchior SW, Corey E, Ellis WJ, Ross AA, Layton TJ, Oswin MM, et al. Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate. Clin Cancer Res 1997;2:249-56. Marchant FE, Lowry LD, Moffitt JJ, et al. Current trends in posttreatment follow-up of patients with SCCA of the head and neck. Am J Otolaryngol 1993;14:88-93. Pantel K, Dickmanns A, Zippelius A, Klein C, Shi J, Hoechtlen-Vollmar W, et al. Establishment of micrometastatic carcinoma cell lines: a novel source of tumor cell vaccines. J Natl Cancer Inst 1995;87:1162-8. Rhee D, Wenig B, Smith R. The significance of immunohistochemically demonstrated nodal micrometastases in patients with squamous cell carcinoma of the head and neck. Laryngoscope. 2002;112:1970-4. Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer 1990;66:109-13. Shah JP. Cervical lymph node metastases: diagnostic, therapeutic, and prognostic implications. Oncology 1990;4:61-9. Snow GB, Annyas AA, Slooten EA van, Bartelink H, Hart AAM. Prognostic factors of neck node metastasis. Clin Otolaryngol 1982;7:185-92. Schuller DE, McGuirt WF, McCabe BF, et al. The prognostic significance of metastatic cervical lymph nodes. Laryngoscope 1980;90:557-70. Schurman SH, Sharon N, Goldschmidt RA, Scanlon EF. Improveddetection of metastases to lymph nodes and estrogenreceptor determination. Arch Surg 1990;125:173-82. Toker C. Some observations on the deposition of metastaticcarcinoma within cervical lymph nodes. Cancer 1963;16:364-74. Tarin D. Metastasis: secondary proliferation in distant organs. In: Pusztai L, Lewis CE, Yap E (eds) Cell Proliferation in Cancer. UK: Oxford University press, 1996; 316-41. White D, Byers RM. What is the preferred initial method oftreatment for squamous carcinoma of the tongue. Am J Surg 1980;140:553-5. Woolgar JA, Scott J, Vaughan ED, Brown JS, West CR, Rogers S. Survival, metastasis and recurrence of oral cancer in relation to pathological features. Ann R Coll Surg Engl 1995;77: 325-31. Woolgar JA, Scott J, Vaughan ED, Brown JS. Pathological findings in clinically false-negative and false-positive neck dissections for oral carcinoma. Ann R Coll Surg Engl 1994;76: 237-44. Woolgar JA, Beirne JC, Vaughan ED, Lewis-Jones HG, Scott J, Brown JS. Correlation of histopathologic findings with clinical and radiologic assessments of cervical lymph-node metastases in oral cancer. Int J Oral Maxillofac Surg 1995;24:30-7. Woolgar JA. Detailed topography of cervical lymph-node metastases from oral squamous cell carcinoma. Int J Oral Maxillofac Surg 1997;26:3–9. Van den Brekel MWM, Stel HV, van der Valk P, van der Waal I, Meyer CJLM, Snow GB. Micrometastases from squamous cell carcinoma in neck dissection specimens. Eur Arch Otolaryngol 1992;249:349-53. Van den Brekel MVM, Stel HV, Castelijns JA, Croll GJ, Snow GB. Lymph node staging in patients with clinically negative neck examinations by ultrasound and ultrasound-guided aspiration cytology. Am J Surg 1991;162:362-6. Van den Brekel MVM vander Waal I, Meijer CJLM, Freeman JL, Castelijns JA, Snow GB. The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope 1996;106:987-91. Van de Brakel MWM, Stel HV, Van de Valk P, et al. Micrometastases from squamous cell carcinoma in neck dissection specimens. Eur Arch Otorhinolaryngol 1992;249:349-53. Yuen APW, Lam KY, Chan ACL, Wei WI, Lam LK, Ho WK, et al. Clinicopathological analysis of elective neck dissection for N0 neck of early oral tongue carcinoma. Am J Surg 1999;177:90-2. Yasuda K, Adachi Y, Shiraishi N, Yamaguchi K, Hirabayashi Y, Kitano S. Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol 2001;8:300-4. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37920 | - |
dc.description.abstract | 背景和目的:例行性的病理切片檢查利用H&E染色,有時很難檢查出頸部淋巴結之微小轉移(小於三公釐),我們的實驗評估是否細胞角質免疫組織化學染色,可以比傳統H&E染色法,更容易檢查出微小轉移,研究口腔鱗狀細胞癌病人頸部微小轉移的特徵,及僅有頸部微小轉移口腔鱗狀細胞癌病人的臨床預後.
材料和方法:利用傳統H&E染色和細胞角質免疫組織化學染色, 檢查取自94例口腔鱗狀細胞癌病人,共2486顆頸部淋巴結的癌轉移情況. 結果:傳統H&E染色可檢查出十五顆淋巴結具微小轉移,四十顆淋巴結有明顯轉移。而使用細胞角質免疫組織化學染色,可多檢查出五顆微小轉移的淋巴結和一顆明顯轉移的淋巴結。數據顯示對淋巴結微小轉移而言,細胞角質免疫組織化學染色,沒有比傳統H&E染色有較佳之檢出率(P = 0.497)。利用細胞角質免疫組織化學染色檢查出的二十個微小轉移,九個發生在八個病人之頸部淋巴結,十一個發生在十一個有明顯轉移病人之頸部淋巴結。只有微小轉移的八個病人中,兩人(25%)有頸部復發的情況,且一人死於頸部癌轉移。二十個微小轉移,有十四個發生在小於十公釐的淋巴結,且十個(50%)發生在五到十公釐的淋巴結。而二十個微小轉移有十一個(55%)發生在淋巴結的邊緣腔中,其它九個(45%)發生在淋巴結的內部髓腔中. 結論:細胞角質免疫組織化學染色,確實可以增加微小轉移的發現率,但和傳統H&E染色比,沒有顯著的差異。口腔鱗狀細胞癌病人之頸部癌轉移中,約百分之三十為微小轉移。微小轉移較常發生在淋巴結的邊緣腔,且通常發生在小於十公釐的淋巴結,基於我們的研究結果發現,我們認為微小轉移可能造成頸部復發疾病,也可能造成口腔鱗狀細胞癌病人之死亡。 | zh_TW |
dc.description.abstract | Background and purposes: Micrometastases (< 3 mm in diameter) in lymph nodes (LNs) are sometimes difficult to detect by routine hematoxylin and eosin (H&E) stain. Our study was designed to find out whether pan-cytokeratin immunostain could have a better detection rate of micrometastasis than H&E stain, to study the characteristic features of micrometastasis in cervical LNs of oral squamous cell carcinoma (OSCC) patients, and to understand the outcome of patients with only micrometastases.
Materials and methods: A total of 2486 cervical LNs from 94 OSCC patients were examined by both H&E stain and pan-cytokeratin immunostain. Results: H&E stain detected 15 LNs with micrometastasis and 40 LNs with overt metastasis. Pan-cytokeratin immunostain identified 5 additional LNs with micrometastasis and 1 additional LN with overt metastasis. Pan-cytokeratin immunostain did not have a significantly better detection rate of micrometastasis than H&E stain (P = 0.497). Of these 20 micrometastases detected by pan-cytokeratin immunostain, 9 occurred in 8 patients with only micrometastases and 11 occurred in 11 patients with both overt metastases and micrometastases. Two (25%) of the 8 patients with only micrometastases developed recurrent disease in the neck and one of the 8 died of neck metastasis. Fourteen (70%) of the 20 micrometastases occurred in LNs smaller than 10 mm in diameter, and 10 (50%) occurred in LNs between 5 mm and 10 mm in diameter. Eleven (55%) of 20 micrometastatic foci were located in the marginal sinuses of the LNs, whereas the remaining 9 (45%) micrometastatic foci were observed in the medullary sinuses of the LNs. Conclusions: Pan-cytokeratin immunostain can increase the detection rate of micrometastasis but it has no significant diagnostic superiority to H&E stain. Approximately 30% of positive cervical LNs of OSCC patients have only micrometastases. Micrometastases are frequently located in the marginal sinuses of the LNs and often found in the LNs smaller than 10 mm in diameter. Based on our findings, we suggest that micrometastatic foci can subsequently result in a recurrent neck disease or finally cause the mortality of the OSCC patient. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T15:51:12Z (GMT). No. of bitstreams: 1 ntu-97-R95422002-1.pdf: 6044507 bytes, checksum: 1d51320199b45721651db0890c92e073 (MD5) Previous issue date: 2008 | en |
dc.description.tableofcontents | 口試委員會審定書
中文摘要 4 Abstract 5 Introduction 7 Purposes of this study 9 Literature Review 10 (i)Lymph node metastasis in squamous cell carcinomas 10 (ii)Occult Metastasis in squamous cell carcinomas 12 (iii)Micrometastasis in squamous cell carcinomas 15 (iv)Increase Detection Rate of Micrometastasis 16 Materials and Methods (i) Patients and specimens 23 (ii) Pan-cytokeratin immunostain 24 (iii) Statistical analysis 27 Results 28 Discussion 31 Conclusions 36 References 37 Tables 43 Figures 49 | |
dc.language.iso | en | |
dc.title | 使用免疫組織化學染色檢查口腔鱗狀細胞癌病人頸部淋巴結之微小轉移 | zh_TW |
dc.title | The Usefulness of Cytokeratin Immunohistochemistry in Detection of Micrometastasis in Neck Lymph Nodes of Oral Cancer Patients | en |
dc.type | Thesis | |
dc.date.schoolyear | 96-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 關學婉,張龍昌 | |
dc.subject.keyword | 微小轉移,口腔癌,臨床預後, | zh_TW |
dc.subject.keyword | micrometastasis,squamous cell carcinoma,clinical outcome, | en |
dc.relation.page | 52 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2008-06-26 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 臨床牙醫學研究所 | zh_TW |
顯示於系所單位: | 臨床牙醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf 目前未授權公開取用 | 5.9 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。